We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
5951
Iovance Biotherapeutics
IOVA
$2.09B
$11K ﹤0.01%
1,457
-1,212
-45% -$8.88K
JOF
5952
Japan Smaller Capitalization Fund
JOF
$322M
$11K ﹤0.01%
1,000
LGIH icon
5953
LGI Homes
LGIH
$1.33B
$11K ﹤0.01%
328
-18,128
-98% -$553K
MOD icon
5954
Modine Manufacturing
MOD
$10.3B
$11K ﹤0.01%
889
+179
+25% +$2.23K
MYE icon
5955
Myers Industries
MYE
$1.24B
$11K ﹤0.01%
672
-171
-20% -$2.43K
NERV icon
5956
Minerva Neurosciences
NERV
$187M
$11K ﹤0.01%
161
-485
-75% -$37.7K
NRC icon
5957
NRC Health Common Stock
NRC
$419M
$11K ﹤0.01%
576
+287
+99% +$5.31K
OII icon
5958
CALL
Oceaneering
OII
$4.74B
$11K ﹤0.01%
+400
New +$10.9K
TMV icon
5959
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$183M
$11K ﹤0.01%
196
-7,598
-97% -$439K
TOVX icon
5960
Theriva Biologics
TOVX
$9.64M
$11K ﹤0.01%
+2
New +$14K
WK icon
5961
Workiva
WK
$3.29B
$11K ﹤0.01%
700
+314
+81% +$4.41K
VIVS
5962
VivoSim Labs
VIVS
$1.35M
$11K ﹤0.01%
16
-71
-82% -$56.2K
VIVO
5963
PUT
DELISTED
Meridian Bioscience Inc
VIVO
$11K ﹤0.01%
800
-2,500
-76% -$35K
FLIR
5964
PUT
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$11K ﹤0.01%
300
-200
-40% -$7.21K
ONDK
5965
DELISTED
On Deck Capital, Inc.
ONDK
$11K ﹤0.01%
2,203
+1,805
+454% +$9.03K
SEMG
5966
CALL
DELISTED
SEMGROUP CORPORATION
SEMG
$11K ﹤0.01%
300
LAYN
5967
DELISTED
Layne Christensen Co
LAYN
$11K ﹤0.01%
1,189
+550
+86% +$5.4K
ATW
5968
PUT
DELISTED
Atwood Oceanics
ATW
$11K ﹤0.01%
1,200
-2,100
-64% -$23.5K
NVDQ
5969
DELISTED
Novadaq Technologies Inc.
NVDQ
$11K ﹤0.01%
+1,400
New +$9.93K
STFC
5970
DELISTED
State Auto Financial Corp
STFC
$11K ﹤0.01%
399
+55
+16% +$1.45K
AIR icon
5971
CALL
AAR Corp
AIR
$5.56B
$10K ﹤0.01%
300
-4,400
-94% -$146K
CERS icon
5972
Cerus
CERS
$579M
$10K ﹤0.01%
2,310
-8,757
-79% -$37.1K
ELDN icon
5973
Eledon Pharmaceuticals
ELDN
$263M
$10K ﹤0.01%
76
+51
+204% +$7.49K
EQNR icon
5974
Equinor
EQNR
$96.8B
$10K ﹤0.01%
623
-1,100
-64% -$19.8K
FCBC icon
5975
First Community Bankshares
FCBC
$899M
$10K ﹤0.01%
400
-149
-27% -$4.08K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.